Literature DB >> 15016844

Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.

Agatha Masemola1, Tumelo Mashishi, Greg Khoury, Phineas Mohube, Pauline Mokgotho, Efthyia Vardas, Mark Colvin, Lynn Zijenah, David Katzenstein, Rosemary Musonda, Susan Allen, Newton Kumwenda, Taha Taha, Glenda Gray, James McIntyre, Salim Abdool Karim, Haynes W Sheppard, Clive M Gray.   

Abstract

An understanding of the relationship between the breadth and magnitude of T-cell epitope responses and viral loads is important for the design of effective vaccines. For this study, we screened a cohort of 46 subtype C human immunodeficiency virus type 1 (HIV-1)-infected individuals for T-cell responses against a panel of peptides corresponding to the complete subtype C genome. We used a gamma interferon ELISPOT assay to explore the hypothesis that patterns of T-cell responses across the expressed HIV-1 genome correlate with viral control. The estimated median time from seroconversion to response for the cohort was 13 months, and the order of cumulative T-cell responses against HIV proteins was as follows: Nef > Gag > Pol > Env > Vif > Rev > Vpr > Tat > Vpu. Nef was the most intensely targeted protein, with 97.5% of the epitopes being clustered within 119 amino acids, constituting almost one-third of the responses across the expressed genome. The second most targeted region was p24, comprising 17% of the responses. There was no correlation between viral load and the breadth of responses, but there was a weak positive correlation (r = 0.297; P = 0.034) between viral load and the total magnitude of responses, implying that the magnitude of T-cell recognition did not contribute to viral control. When hierarchical patterns of recognition were correlated with the viral load, preferential targeting of Gag was significantly (r = 0.445; P = 0.0025) associated with viral control. These data suggest that preferential targeting of Gag epitopes, rather than the breadth or magnitude of the response across the genome, may be an important marker of immune efficacy. These data have significance for the design of vaccines and for interpretation of vaccine-induced responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016844      PMCID: PMC371059          DOI: 10.1128/jvi.78.7.3233-3243.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians.

Authors:  M R Betts; J Krowka; C Santamaria; K Balsamo; F Gao; G Mulundu; C Luo; N N'Gandu; H Sheppard; B H Hahn; S Allen; J A Frelinger
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Diversity of the vif gene of human immunodeficiency virus type 1 in Uganda.

Authors:  U Wieland; A Seelhoff; A Hofmann; J E Kühn; H J Eggers; P Mugyenyi; S Schwander
Journal:  J Gen Virol       Date:  1997-02       Impact factor: 3.891

3.  Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

Authors:  T Harrer; E Harrer; S A Kalams; T Elbeik; S I Staprans; M B Feinberg; Y Cao; D D Ho; T Yilma; A M Caliendo; R P Johnson; S P Buchbinder; B D Walker
Journal:  AIDS Res Hum Retroviruses       Date:  1996-05-01       Impact factor: 2.205

4.  Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

Authors:  T Harrer; E Harrer; S A Kalams; P Barbosa; A Trocha; R P Johnson; T Elbeik; M B Feinberg; S P Buchbinder; B D Walker
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

5.  An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa.

Authors:  J van Harmelen; R Wood; M Lambrick; E P Rybicki; A L Williamson; C Williamson
Journal:  AIDS       Date:  1997-01       Impact factor: 4.177

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.

Authors:  Jianhong Cao; John McNevin; Sarah Holte; Lisa Fink; Lawrence Corey; M Juliana McElrath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.

Authors:  C Rinaldo; X L Huang; Z F Fan; M Ding; L Beltz; A Logar; D Panicali; G Mazzara; J Liebmann; M Cottrill
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

9.  Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.

Authors:  Marcus Altfeld; Marylyn M Addo; Raj Shankarappa; Paul K Lee; Todd M Allen; Xu G Yu; Almas Rathod; Jason Harlow; Kristin O'Sullivan; Mary N Johnston; Philip J R Goulder; James I Mullins; Eric S Rosenberg; Christian Brander; Bette Korber; Bruce D Walker
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

Authors:  M R Klein; C A van Baalen; A M Holwerda; S R Kerkhof Garde; R J Bende; I P Keet; J K Eeftinck-Schattenkerk; A D Osterhaus; H Schuitemaker; F Miedema
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  116 in total

1.  Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia.

Authors:  Otto O Yang; Eric S Daar; Hwee L Ng; Roger Shih; Beth D Jamieson
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-18       Impact factor: 2.205

2.  Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replication.

Authors:  Chungwon Chung; Wonhee Lee; John T Loffredo; Benjamin Burwitz; Thomas C Friedrich; Juan Pablo Giraldo Vela; Gnankang Napoe; Eva G Rakasz; Nancy A Wilson; David B Allison; David I Watkins
Journal:  J Virol       Date:  2006-11-29       Impact factor: 5.103

Review 3.  Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection.

Authors:  George Makedonas; Michael R Betts
Journal:  Springer Semin Immunopathol       Date:  2006-08-25

4.  HIV viral diversity and escape from cellular immunity.

Authors:  Nicole Frahm; Christian Brander
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

5.  Transmission and long-term stability of compensated CD8 escape mutations.

Authors:  Arne Schneidewind; Zabrina L Brumme; Chanson J Brumme; Karen A Power; Laura L Reyor; Kristin O'Sullivan; Adrianne Gladden; Ursula Hempel; Thomas Kuntzen; Yaoyu E Wang; Cesar Oniangue-Ndza; Heiko Jessen; Martin Markowitz; Eric S Rosenberg; Rafick-Pierre Sékaly; Anthony D Kelleher; Bruce D Walker; Todd M Allen
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

6.  Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals.

Authors:  Sanjay Mendiratta; Madhu Vajpayee; Uma Malhotra; Shweta Kaushik; Lalit Dar; Kamalika Mojumdar; Neeraj Kumar Chauhan; Vishnubhatla Sreenivas
Journal:  Med Microbiol Immunol       Date:  2008-11-05       Impact factor: 3.402

7.  Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.

Authors:  Diana Y Chen; Arumugam Balamurugan; Hwee L Ng; William G Cumberland; Otto O Yang
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

8.  Efavirenz stimulates HIV-1 reverse transcriptase RNase H activity by a mechanism involving increased substrate binding and secondary cleavage activity.

Authors:  John M Muchiri; Dongge Li; Carrie Dykes; Robert A Bambara
Journal:  Biochemistry       Date:  2013-07-09       Impact factor: 3.162

9.  Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cells.

Authors:  Nami Iwamoto; Naofumi Takahashi; Sayuri Seki; Takushi Nomura; Hiroyuki Yamamoto; Makoto Inoue; Tsugumine Shu; Taeko K Naruse; Akinori Kimura; Tetsuro Matano
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

10.  Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.

Authors:  Mark J Geels; Sheri A Dubey; Kiersten Anderson; Elly Baan; Margreet Bakker; Georgios Pollakis; William A Paxton; John W Shiver; Jaap Goudsmit
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.